NCT05157412View on ClinicalTrials.gov

Role of Doxycycline in Chronic Rhinosinusitis With Nasal Polyps

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

September 1, 2023

Study Completion Date

January 1, 2024

Conditions
Nasal PolypsChronic Rhinosinusitis With Nasal Polyps
Interventions
DRUG

Doxycycline 100 mg Oral Tablet

Oral Doxycycline will be added to prednisolone as a comparison to using prednisolone as a sole therapy for the treatment of nasal polyps associated with chronic rhinosinusitis

DRUG

Prednisolone 20 mg

Prednisolone will be used in both arms as a sole therapy in one and together with doxycycline in the other

Trial Locations (1)

71111

Assiut University Hospital, Asyut

All Listed Sponsors
lead

Assiut University

OTHER